Professor and Senior Scientist Hemocentro Unicamp Campinas, Sao Paulo
This lecture explores how cutting-edge immunohematology research is translated into real-world clinical transfusion practice. It highlights the integration of laboratory discoveries and advanced molecular approaches to enhance transfusion safety and optimize patient outcomes. With a special focus on the genetic and demographic diversity of Latin American populations, this session offers valuable insights for professionals seeking to apply innovative science to everyday transfusion challenges
2026 Recipient: Lilian Maria de Castilho, PhD (citation) In recognition of her many essential leadership and research in the field of blood and biotherapies. In addition to her work on more than 200 scientific studies, Dr. Castilho has helped to bring transformative advancements to the field in Latin America through her education and mentorship initiatives. Throughout her career, she has trained hundreds of blood and biotherapies professionals in Latin America and has made lasting contributions to advance quality and safety throughout the region.
About the Sally Frank Memorial Award and Lectureship This award was established in 1982 in memory of Sally Frank and her dedication to red cell serology and education. This award recognizes an individual who is, or has been, a medical technologist involved with these fields and has demonstrated quality research, teaching and/or service abilities in the technical aspects of immunohematology. The Sally Frank Memorial Award and Lectureship is presented annually, and recipient is selected one year in advance. This award is funded through an endowment from Sally Frank’s family, friends, and colleagues.
Learning Objectives:
Explain how molecular immunohematology has enhanced transfusion safety by improving detection of blood group variants and reducing alloimmunization risk in diverse populations.
Describe the unique challenges and opportunities in Latin America, including genetic diversity, resource limitations, and the adoption of advanced transfusion practices.
Identify practical strategies for translating scientific advances into clinical practice, such as extended antigen matching, donor genotyping, rare donor programs, and regional collaborations.
Discuss how research, education, and capacity building can drive sustainable improvements in transfusion medicine and immunohematology.
